NCT00224263View on ClinicalTrials.gov

Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

February 29, 2008

Conditions
Parkinson's Disease
Interventions
DRUG

Lingzhi (Ganoderma)

Trial Locations (1)

Unknown

Xuanwu Hospital, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT00224263 - Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease | Biotech Hunter | Biotech Hunter